>6 months at -80°C.
1. Spiegelberg, B.D. and Hamm, H.E. (2005) J. Biol. Chem. 280, 41769-41776
2. Waltregny et al., (2004) J. Neural Transm. 48, 273-290.
Application References:
1. An azumamide C analogue without the zinc-binding functionality (2017)
2. Impact of binding mechanism on selective inhibition of histone deacetylase isoforms (2017)
3. Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents (2014)
4. Identification and characterization of small-molecule inhibitors of lysine acetyltransferases (2014)
5. In Vivo Imaging of Histone Deacetylases (HDACs) in the Central Nervous System and Major Peripheral Organs (2014)
6. The effect of various zinc binding groups on inhibition of histone deacetylases 1-11 (2014)
7. A selective HDAC 1/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests (2013)
8. Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity (2013)
9. FDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors (2013)